524322 KABRADG

Kabra Drugs Share Price

 

 

Kabra Drugs live price: ₹28.29. It opened at ₹29 vs previous close ₹29; intraday high/low: ₹29/₹28. The 50 & 200 DMA stand at ₹28.47/₹23.64.

Kabra Drugs Performance

  • Today's Low
  • ₹28
  • Today's High
  • ₹29
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹36
  • Open Price₹29
  • Previous Close₹29
  • Volume48,050
  • 50 DMA₹28.47
  • 100 DMA₹27.40
  • 200 DMA₹23.64

Investment Returns

  • Over 1 Month -5.51%
  • Over 3 Month + 1.07%
  • Over 6 Month + 48.43%
  • Over 1 Year + 155.32%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 15.6
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 67
  • P/B Ratio
  • 2.3
  • Average True Range
  • 1.63
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.87
  • RSI
  • 51.38
  • MFI
  • 32.18

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹28.29
-0.25 (-0.88%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹27.76
  • 50 Day
  • ₹28.47
  • 100 Day
  • ₹27.40
  • 200 Day
  • ₹23.64

Resistance and Support

28.56 Pivot Speed
  • R3 30.35
  • R2 29.84
  • R1 29.07
  • S1 27.79
  • S2 27.28
  • S3 26.51

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-21 Others
2026-03-07 Others Inter-alia, to consider 1. Proposal for changing the name of the company. 2. Strategic expansion of business operations in Indonesia and Canada. 3. Other business matters.
2026-02-13 Quarterly Results
2025-11-28 Others Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion.
2025-11-13 Quarterly Results

Kabra Drugs F&O

Kabra Drugs Shareholding Pattern

0%
91.43%
8.57%

Kabra Drugs FAQs

Kabra Drugs share price is ₹28 As on 12 April, 2026 | 14:02

The Market Cap of Kabra Drugs is ₹67.1 Cr As on 12 April, 2026 | 14:02

The P/E ratio of Kabra Drugs is 15.6 As on 12 April, 2026 | 14:02

The PB ratio of Kabra Drugs is 2.3 As on 12 April, 2026 | 14:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23